Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Jun 26, 2021 12:12am
43 Views
Post# 33455284

RE:RE:RE:$70M cash with priority voucher sale

RE:RE:RE:$70M cash with priority voucher sale
stockbuphoon wrote:

Where's the $50 and $100 pumping? Who's lying? You are a piece of work. 

They are already spending the $17M and they get $5M this week. You did read press release that said they continue to pay Ryplazim costs until they sell PRV so $8M a month and they only had $21M March 31, 2021 but I digress. I have to say that I have never argued with someone who assumes everyone never reads analyst reports (like you) or even press releases. Like a democrat! $70M with a PR on may 28th that clearly stops their best chance of any clinical success to partner an indication. You never ever talk about business potential. You talk about share price appreciation on getting financing of $70M which they have no plan for. What are they taking to clinic? Crickets.. as usual. You are enticing so many to buy. Incredible

the Company has decided to stop its plans to move fezagepras into a Phase II clinical study in Idiopathic Pulmonary Fibrosis and a phase Ia/IIb study in Hypertriglyceridemia, as it evaluates the impact of the PK data profile observed in the on-going study.

 

realstocky wrote:

 

70M$ + 17M + 5M + 3M =?   ($u.s.)  Dont ask your twin plitheone to ad all that. On a burn rate of less than 5M$/month, we gucci for a while:) Wonder what the sp will do though on the money influx of the voucher and with a market cap of only 120M$. I guess thats why u are here all day, everyday though:^)

 

read the NR on pbi4050, all u do is missinform people and LIE... lie about the FDA impossibility to travel and inspect a plant in canada, lie about pbi4050, lie about the production jobs being fake and only as a threat to kedrion. 

by the way, did u find out what those production employes will produce?  Come on, i know u know:)

https://liminalbiosciences.com/careers/laval/

U could at least make some smileys on your posts so they wouldnt be so sad.
 





<< Previous
Bullboard Posts
Next >>